Research impact
Over 60 years, we've invested more than £500 million in blood cancer research which has led to a long line of breakthroughs that have improved treatments and saved lives.
Together we’ve achieved an incredible amount in the last 60 years, but there’s still much more to be done before we see a day where blood cancer is finally beaten.

Our research impact on leukaemia

Our research impact on childhood leukaemia

Our research impact on myeloma

Our research impact on lymphoma

Our research impact across all blood cancers and beyond

How our research helps other types of cancers
